Wyandot Memorial Hospital | |
885 North Sandusky Avenue, Upper Sandusky, Ohio 43351 | |
(419) 294-4991 | |
Name | Wyandot Memorial Hospital |
---|---|
Type | Critical Access Hospital |
Location | 885 North Sandusky Avenue, Upper Sandusky, Ohio |
Ownership | Government - Hospital District or Authority |
Emergency Services | Yes |
Medicare ID (CCN) | 361329 |
NPI Number | 1174605695 |
Organization Name | WYANDOT MEMORIAL HOSPITAL |
Address | 885 N Sandusky Ave, Upper Sandusky, OH 43351 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 419-294-4991 |
News Archive
On February 28th, Harvey Karp, MD, FAAP, Assistant Professor at the USC School of Medicine, will present the keynote address on the prevention of Shaken Baby Syndrome at the 25th Annual Conference of Prevent Child Abuse Texas, in Dallas.
PharmaMar today announced the start of a multicenter, prospective, pivotal study to analyze the efficacy of the antitumoral compound of marine origin, plitidepsin in patients with relapsed and refractory angioimmunoblastic T-cell lymphoma.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
› Verified 2 days ago
NPI Number | 1477554475 |
Organization Name | WYANDOT MEMORIAL HOSPITAL |
Address | 885 N Sandusky Ave, Upper Sandusky, OH 43351 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 419-294-4991 |
News Archive
On February 28th, Harvey Karp, MD, FAAP, Assistant Professor at the USC School of Medicine, will present the keynote address on the prevention of Shaken Baby Syndrome at the 25th Annual Conference of Prevent Child Abuse Texas, in Dallas.
PharmaMar today announced the start of a multicenter, prospective, pivotal study to analyze the efficacy of the antitumoral compound of marine origin, plitidepsin in patients with relapsed and refractory angioimmunoblastic T-cell lymphoma.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
› Verified 2 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
On February 28th, Harvey Karp, MD, FAAP, Assistant Professor at the USC School of Medicine, will present the keynote address on the prevention of Shaken Baby Syndrome at the 25th Annual Conference of Prevent Child Abuse Texas, in Dallas.
PharmaMar today announced the start of a multicenter, prospective, pivotal study to analyze the efficacy of the antitumoral compound of marine origin, plitidepsin in patients with relapsed and refractory angioimmunoblastic T-cell lymphoma.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
› Verified 2 days ago
Wyandot Memorial Hospital Critical Access Hospital Location: 885 North Sandusky Avenue, Upper Sandusky, Ohio 43351 Phone: (419) 294-4991 |